A paclitaxel-coated balloon, Agent DCB (Boston Scientific), was superior to an uncoated balloon for treating coronary in-stent restenosis in patients undergoing percutaneous coronary intervention (PCI ...

Please provide your email address to receive an email when new articles are posted on . A sirolimus-eluting balloon was noninferior to drug-eluting stents in treating de novo coronary lesions. The ...

Please provide your email address to receive an email when new articles are posted on . Balloon angioplasty and stent implantation procedures in the early postoperative period after congenital heart ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These ...

Compared with standard balloon angioplasty, the drug-coated balloon strategy appeared to suppress recurrent ISR over six months in a 52-patient study, published online November 13, 2006 in the New ...

Scripps Clinic interventional cardiologist Paul Teirstein, M.D., became the first in Southern California to use a newly approved drug-coated balloon to clear a clogged stent that previously had been ...

MINNEAPOLIS –– Advancing the treatment of peripheral artery disease, Medtronic, Inc. today announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant® Cobalt Iliac ...

Stent grafts may be more effective than balloon angioplasty in prolonging the function of stenosed arteriovenous access grafts and in lowering the likelihood of requiring additional interventions, ...

Johns Hopkins surgeons say skipping one commonly taken step during a routine procedure to insert a wire mesh stent into a partially blocked carotid artery appears to prevent patients from developing ...